<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="45026">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01651026</url>
  </required_header>
  <id_info>
    <org_study_id>CROSS-1</org_study_id>
    <nct_id>NCT01651026</nct_id>
  </id_info>
  <brief_title>Multicenter Cohort Prospective Study on Multidisciplinary Treatment of Rectal Cancer</brief_title>
  <acronym>CROSS-1</acronym>
  <official_title>Multicentered Observational Prospective Cohort Study on Multidisciplinary Treatment of Rectal Cancer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Cancer Institute, Naples</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Cancer Institute, Naples</source>
  <oversight_info>
    <authority>Italy: Ethics Committee</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to describe the diagnostic and treatment procedures employed
      for patients with rectal cancer in each participating center.  Outcomes to treatment, costs
      of treatment will be described. Exploratory analyses will be done to identify factor that
      influence patient prognosis, as well as factors that predict patient response to treatment.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2011</start_date>
  <completion_date type="Anticipated">May 2017</completion_date>
  <primary_completion_date type="Anticipated">May 2016</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>list of diagnostic procedures used in clinical practice, according to participating Institute</measure>
    <time_frame>5 years</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <other_outcome>
    <measure>all treatments received for colorectal cancer (surgery, radiation therapy, chemotherapy, supportive care, etc) per patient</measure>
    <time_frame>5 years</time_frame>
    <safety_issue>No</safety_issue>
  </other_outcome>
  <other_outcome>
    <measure>rectal cancer surgical interventions/approaches per participating center</measure>
    <time_frame>5 years</time_frame>
    <safety_issue>No</safety_issue>
  </other_outcome>
  <other_outcome>
    <measure>disease outcomes per patient per treatment received</measure>
    <time_frame>5 years</time_frame>
    <safety_issue>No</safety_issue>
  </other_outcome>
  <other_outcome>
    <measure>estimated costs per treatment pattern per center</measure>
    <time_frame>5 years</time_frame>
    <safety_issue>No</safety_issue>
  </other_outcome>
  <other_outcome>
    <measure>factors that influence patient prognosis</measure>
    <time_frame>5 years</time_frame>
    <safety_issue>No</safety_issue>
    <description>exploratory analyses</description>
  </other_outcome>
  <other_outcome>
    <measure>predictive factors for response to treatment</measure>
    <time_frame>5 years</time_frame>
    <safety_issue>No</safety_issue>
    <description>exploratory analyses</description>
  </other_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">600</enrollment>
  <condition>Metastatic Colorectal Cancer</condition>
  <arm_group>
    <arm_group_label>rectal cancer</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Consecutive patients at participating Institutes with confirmed diagnosis of colorectal
        cancer.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Histologic diagnosis rectal carcinoma

          -  Signed informed consent

        Exclusion Criteria:

          -  Refusal or incapability of providing informed consent
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>G. Romano, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>National Cancer Institute, Naples</affiliation>
  </overall_official>
  <overall_official>
    <last_name>C. Sassaroli, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>National Cancer Institute, Naples</affiliation>
  </overall_official>
  <overall_official>
    <last_name>M. C. Piccirillo, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>National Cancer Institute, Naples</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Francesco Perrone, M.D., Ph.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>National Cancer Institute, Naples</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Francesco Perrone, M.D., Ph.D.</last_name>
    <phone>+39 081 5903571</phone>
    <email>francesco.perrone@usc-intnapoli.net</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Marilina Piccirillo, M.D.</last_name>
    <phone>+39 081 5903383</phone>
    <email>marilina.piccirillo@usc-intnapoli.net</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Istituto Nazionale dei Tumori , Oncologia Medica - Dipartimento Entero-proctologico</name>
      <address>
        <city>Napoli</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>A.O.U. Federico II</name>
      <address>
        <city>Napoli</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>A.O.R.N. V. Monaldi</name>
      <address>
        <city>Napoli</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>January 2014</verification_date>
  <lastchanged_date>January 3, 2014</lastchanged_date>
  <firstreceived_date>July 24, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Rectal Neoplasms</mesh_term>
    <mesh_term>Colorectal Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
